(Q42509176)
Statements
1 reference
Phase I study of aurora A kinase inhibitor MLN8237 in advanced solid tumors: safety, pharmacokinetics, pharmacodynamics, and bioavailability of two oral formulations (English)
1 reference
Margaret von Mehren
1 reference
E Claire Dees
1 reference
Roger B Cohen
1 reference
Thomas E Stinchcombe
1 reference
Hua Liu
1 reference
Karthik Venkatakrishnan
1 reference
Mark Manfredi
1 reference
Howard Fingert
1 reference
Howard A Burris
1 reference
Jeffrey R Infante
1 reference
5 July 2012
1 reference
1 reference
18
1 reference
17
1 reference
4775-4784
1 reference
Identifiers
1 reference
1 reference